MHS: Revisiting Ethical Implications for Human Subject Research

A patient consents to HIV genotyping because their physician needs the information to select treatment. The patient is never meaningfully informed that the viral sequence will also enter a government surveillance system. Their sequence is subsequently identified as part of a rapidly growing molecular cluster. Public-health officials then use that classification to decide where and how to intervene. The individual never consented to having their clinical specimen repurposed to map their relationship to a population-level transmission network.

This creates a provocative comparison with conventional research ethics.

If I recruited 5,000 people living with HIV into a university study, collected their viral sequences, linked those sequences to demographic and epidemiological information, constructed molecular clusters, and evaluated interventions based on those clusters, an IRB would scrutinize questions of consent, risk, privacy, data governance, and protection of participants.

Yet when some similar analytical activities occur under the legal category of public-health surveillance, individual informed consent may not be required.

That gives you a powerful question for a research-ethics discussion:

At what point does surveillance become research on human populations?

From a Marxist/Foucauldian perspective, the critique could go further: the state has transformed biological material collected for an individual's medical care into population-level knowledge that permits institutions to classify, map, and intervene upon marginalized populations—without giving those populations equivalent control over the production or use of that knowledge. The ethical issue therefore isn't simply confidentiality; it is also who possesses the power to convert a person's biology into data, define the purposes for which those data may be used, and decide what constitutes an acceptable risk.

That argument is stronger than simply saying “MHS is experimentation without consent,” because the latter is legally debatable. The sharper critique is: classifying MHS as surveillance can permit practices involving systematic secondary analysis and intervention that would face substantially different consent requirements if institutionally classified as human-subjects research.